Vaccines, Blood & Biologics
Support for Clinical Trials Advancing Rare disease Therapeutics (START) Pilot Program
CBER Rare Disease Program Rare diseases and conditions as defined by the Orphan Drug Act (1983) affect
Readmore
Artificial Intelligence and Machine Learning for CBER Regulated Products
Artificial Intelligence and Machine Learning (AI/ML) for Biological and Other Products Regulated by CBER Artificial
Readmore
CBER Product Approval Information
This list includes applications for which we have approval documents available, and reflects the information
Readmore